Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1986 | 06-1985 | 06-1984 | 06-1983 | 06-1982 | |
| Sales | 1,429,000 | 1,185,700 | 915,000 | 1,027,500 | 865,800 |
| Operating Expenses | 1,429,000 | 1,185,700 | 915,000 | 1,027,500 | 865,800 |
| Interest Expense | 7,000 | N/A | N/A | N/A | N/A |
| Other Income | 619,000 | 402,900 | 256,000 | 186,400 | 133,600 |
| Pre-tax Income | 612,000 | 402,900 | 256,000 | 186,400 | 133,600 |
| Income Tax | 209,000 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 403,000 | N/A | N/A | N/A | N/A |
| Minority Interests | -3,000 | N/A | N/A | N/A | N/A |
| Net Income | $400,000 | $N/A | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | 0.34 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.34 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.34 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.34 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $661,000 | $0 | $0 | $0 | $0 |